| abstract |
A composition comprises about 0.25 to 1% w/v of a thioureylene compound, at least about 0.2% w/v of a polysaccharide and a liquid vehicle. The composition may be used in the treatment of diseases and conditions associated with abnormally high thyroid hormone levels in mammals, such as humans and cats. The thioureylene compound may be carbimazole, methimazole, methylthiouracil, or propylthiouracil. Preferably, the composition comprises at least 0.4%w/v of polysaccharide, which may be xanthan gum. The liquid composition may be administered orally. |